NCT06814535View on ClinicalTrials.gov

A Comparative Study on the Impact of Trigger Points Injection of Platelet Rich Plasma Versus Botulinum Toxin on the Relief of Jaw Muscles Myofascial Pain

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions

Patients with Jaw Muscles Myofascial Pain

Interventions

DRUG

Botulinum Toxin A / Botulinum Toxin A

Botulinum toxin type A

DRUG

Platelet rich plasma

Plasma that contains concentrated platelets

DRUG

Saline -- placebo comparator

Physiological saline .9 %

Trial Locations (1)

Unknown

Faculty of dentistry Cairo University, Giza

All Listed Sponsors

lead

Cairo University

OTHER

NCT06814535 - A Comparative Study on the Impact of Trigger Points Injection of Platelet Rich Plasma Versus Botulinum Toxin on the Relief of Jaw Muscles Myofascial Pain | Biotech Hunter | Biotech Hunter